Discontinued — last reported Q3 '24
Life Sciences and Applied Markets — Depreciation
Agilent Technologies Life Sciences and Applied Markets — Depreciation remained flat by 0.0% to $16.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 1.6%, from $15.75M to $16.00M. Over 3 years (FY 2021 to FY 2024), Life Sciences and Applied Markets — Depreciation shows an upward trend with a 13.3% CAGR.
Analysis
How to read this metric
Consistent levels suggest stable capital investment, while significant changes may indicate shifts in the age or scale of the segment's asset base.
Detailed definition
This is the systematic allocation of the cost of tangible assets, such as manufacturing equipment and laboratory facilit...
Peer comparison
Standard accounting metric for capital-intensive industries; peers report this to reconcile EBITDA and cash flow.
a_segment_life_sciences_and_applied_markets_depreciationHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $44.00M | $59.00M | $63.00M | $64.00M |
| YoY Change | — | +34.1% | +6.8% | +1.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's life sciences and applied markets — depreciation?
- Agilent Technologies (A) reported life sciences and applied markets — depreciation of $16.00M in Q3 2024.
- How has Agilent Technologies's life sciences and applied markets — depreciation changed year-over-year?
- Agilent Technologies's life sciences and applied markets — depreciation increased by 1.6% year-over-year, from $15.75M to $16.00M.
- What is the long-term trend for Agilent Technologies's life sciences and applied markets — depreciation?
- Over 3 years (2021 to 2024), Agilent Technologies's life sciences and applied markets — depreciation has grown at a 13.3% compound annual growth rate (CAGR), from $44.00M to $64.00M.
- What does life sciences and applied markets — depreciation mean?
- The non-cash expense representing the aging and usage of the segment's physical assets.